147034-01-3

Basic information

• Product Name: (2,5-dibroMophenyl)Methanol
• Synonyms: (2,5-dibroMophenyl)Methanol;2,5-Dibromobenzyl alcohol;Benzenemethanol, 2,5-dibromo-
• CAS NO: 147034-01-3
• Molecular Formula: C₇H₆Br₂O
• Molecular Weight: 265.92994
• Mol File: 147034-01-3.mol

Chemical Properties

• Boiling Point: 322.6±27.0 °C(Predicted)
• Appearance: /
• Density: 1.960±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.87±0.10(Predicted)
• CAS DataBase Reference: (2,5-dibroMophenyl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2,5-dibroMophenyl)Methanol(147034-01-3)
• EPA Substance Registry System: (2,5-dibroMophenyl)Methanol(147034-01-3)

Safety Data

• Hazardous Substances Data: 147034-01-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(2,5-dibromophenyl)methanol is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to undergo multiple chemical reactions, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, (2,5-dibromophenyl)methanol is utilized as a building block for the synthesis of agrochemicals, such as pesticides and herbicides, due to its reactivity and potential to form a variety of derivatives.
Used as a Reagent in Chemical Synthesis:
(2,5-dibromophenyl)methanol is employed as a reagent in the preparation of various chemical products, including organic compounds and specialty chemicals, owing to its versatility in chemical reactions and its role as an important intermediate in organic synthesis.

Upstream product

• 111-25-1 1-bromo-hexane 
• 74553-29-0 2,5-dibromobenzaldehyde 
• 610-71-9 2,5-dibromobenzoic acid 
• 57381-43-8 2,5-dibromobenzoic acid methyl ester 
• 76008-76-9 2,5-dibromobenzoic acid ethyl ester 
• 615-59-8 1,4-dibromo-2-methylbenzene 
• 147033-99-6 2,5-dibromophenylmethylene diacetate 

Downstream Products

• 74553-29-0 2,5-dibromobenzaldehyde 
• 642091-49-4 2,5-dibromobenzyl chloride 
• 1059111-41-9 C₁₆H₂₆Br₂OSi 
• 136105-40-3 1,4-dibromo-2-(bromomethyl)benzene 
• 168759-64-6 7-bromoisochroman-4-one 
• 74533-21-4 2-(2,5-dibromophenyl)acetonitrile 
• 203314-28-7 2-(2,5-dibromophenyl)-acetic acid 
• 203314-51-6 (2,5-dibromo-phenyl)-acetyl chloride 

Relevant articles and documents

Synthesis of 2,5-dibromobenzaldehyde and its reaction with hexylmagnesium bromide

2,5-Dibromobenzaldehyde (3) is synthesized by the oxidation of 2,5-dibromotoluene (1) via 2,5-dibromobenzylidene diacetate (2). Grignard reaction of hexylmagnesium bromide with 2 gives the normal addition product, 2,5-dibromo-α-hexylbenzyl alcohol (5) and

Strategy for Overcoming Full Reversibility of Intermolecular Radical Addition to Aldehydes: Tandem C-H and C-O Bonds Cleaving Cyclization of (Phenoxymethyl)arenes with Carbonyls to Benzofurans

An intermolecular addition of carbon radicals enabled by a cascade radical coupling strategy is developed. It includes an intermolecular alkyl radical addition to a carbonyl group followed by an intramolecular alkoxy radical addition to haloarenes and produces substituted benzofurans in high yields. The radical nature of this reaction is explored by radical trapping experiments and EPR analysis. The mechanism is investigated by KIE experiments and control experiments. This method could provide rapid and practical access to the key intermediate of TAM-16, a safe and potent antibacterial agent for treating tuberculosis, and, therefore, is of great importance for organic synthesis and the pharmaceutical industry.

ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of the formulas (IA) and (IB) and pharmaceutically acceptable salts thereof, wherein A and R1 - R6, are as defined herein. The invention also relates to pharmaceutical compositions comprisin

Synthesis of oligophenylenevinylene heptamers substituted with fullerene moieties

Oligophenylenevinylene (OPV) derivatives substituted with one or two fullerene subunits have been prepared starting from a fullerene carboxylic acid derivative and OPV heptamers bearing one or two alcohol functions. The electrochemical properties of the resulting C60-OPV derivatives have been investigated by cyclic voltammetry. Whereas the fist reduction of both C60-OPV conjugates is centered on the C60 unit, the oxidation is centered on the OPV rod. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity

The c-Jun N-terminal kinases (JNK-1, -2, and -3) are members of the mitogen activated protein (MAP) kinase family of enzymes. They are activated in response to certain cytokines, as well as by cellular stresses including chemotoxins, peroxides, and irradiation. They have been implicated in the pathology of a variety of different diseases with an inflammatory component including asthma, stroke, Alzheimer's disease, and type 2 diabetes mellitus. In this work, high-throughput screening identified a JNK inhibitor with an excellent kinase selectivity profile. Using X-ray crystallography and biochemical screening to guide our lead optimization, we prepared compounds with inhibitory potencies in the low-double-digit nanomolar range, activity in whole cells, and pharmacokinetics suitable for in vivo use. The new compounds were over 1000-fold selective for JNK-1 and -2 over other MAP kinases including ERK2, p38α, and p38δ and showed little inhibitory activity against a panel of 74 kinases.